Lin-yuan YU, Li-hong GONG, Yun-qiu TANG, et al. Nonalcoholic Fatty Liver Disease Effect of Emodin Based on AMPK Signaling Pathway[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(2): 203-209.
DOI:
Lin-yuan YU, Li-hong GONG, Yun-qiu TANG, et al. Nonalcoholic Fatty Liver Disease Effect of Emodin Based on AMPK Signaling Pathway[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(2): 203-209. DOI: 10.13422/j.cnki.syfjx.20192305.
Nonalcoholic Fatty Liver Disease Effect of Emodin Based on AMPK Signaling Pathway
Emodin is a common Chinese medicine compound with anti-inflammatory
antibacterial
anti-oxidant and lipid-lowering effects. Modern studies have found that emodin activates adenylate-activated protein kinase (AMPK) signaling molecules and regulates transcriptional factors and biological functions of relevant pathways. Nonalcoholic fatty liver disease is a chronic liver disease with a high incidence in China. With the global prevalence of obesity and metabolic syndrome
the development of nonalcoholic fatty liver disease (NAFLD) is closely related to the expression of the metabolism-related signal molecule AMPK. AMPK is a key enzyme in glycolipid metabolism that can involve different stages of NAFLD development to non-alcoholic steatohepatitis (NASH) by regulating energy metabolism in the body. In recent years
many studies have suggested that the activation of AMPK signaling molecules is related to the function realization of emodin
and lipid synthesis
fatty acid oxidation
insulin sensitivity and mitochondrial function-related transcription factors affected by AMPK downstream signaling molecules and other biological effects can be interacted with each other. The detailed mechanism of action associated with AMPK activation provides new thought about the treatment of NAFLD by emodin. This paper mainly summarizes the research progress of emodin by participating in the various stages of NAFLD by AMPK-related signaling pathways through literature retrieval and comprehensive analysis. It lays a foundation for further research on the therapeutic effect and mechanism of emodin on NAFLD.
B K Smith , K Marcinko , E M Desjardins , et al . Treatment of nonalcoholic fatty liver disease: role of AMPK [J]. Am J Physiol Endocrinol Metab , 2016 , 311 ( 4 ): E730 - E740 .
Z CHEN , L ZHANG , J YI , et al . Promotion of adiponectin multimerization by emodin: a novel AMPK activator with PPAR γ -agonist activity [J]. J Cell Biochem , 2012 , 113 ( 11 ): 3547 - 3558 .
F Yap , L Craddock , J YANG . Mechanism of AMPK Suppression of LXR-dependent Srebp-1c transcription [J]. Int J Biol Sci , 2011 , 7 ( 5 ): 645 - 650 .
H Y QUAN , D Y Kim , S J Kim , et al . Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway [J]. Biochem Pharmacol , 2013 , 85 ( 9 ): 1330 - 1340 .
S WANG , X LI , H GUO , et al . Emodin alleviates hepatic steatosis by inhibiting SREBP1 activity via the CaMKK-AMPK-mTOR-p70S6K signaling pathway [J]. Hepatol Res , 2016 , 47 ( 7 ): 683 - 701 .
P Song , J H Kim , J Ghim , et al . Emodin regulates glucose utilization by activating AMP-activated protein kinase [J]. J Biol Chem , 2013 , 288 ( 8 ): 5732 - 5742 .
M Choudhury , I Qadri , S M Rahman , et al . C/EBPβ is AMP kinase sensitive and up-regulates PEPCK in response to ER stress in hepatoma cells [J]. Mol Cell Endocrinol , 2011 , 331 ( 1 ): 102 - 108 .
N Maeda , M Takahashi , T Funahashi , et al . PPAR γ ligands increase expression and plasma concentrations of adiponectin,an adipose-derived protein [J]. Diabetes , 2001 , 50 ( 9 ): 2094 - 2099 .
A Salminen , J M T Hyttinen , K Kaarniranta . AMP-activated protein kinase inhibits NF- κ B signaling and inflammation: impact on healthspan and lifespan [J]. J Mol Med:Berl , 2011 , 89 ( 7 ): 667 - 676 .
L TAO , F CAO , G XU , et al . Mogroside IIIE attenuates LPS-induced acute lung injury in mice partly through regulation of the TLR4/MAPK/NF- κ B Axis via AMPK activation [J]. Phytother Res , 2017 , 31 ( 7 ): 1097 - 1106 .
X JIA , S Iwanowycz , J WANG , et al . Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides [J]. Exp Biol Med:Maywood , 2014 , 239 ( 8 ): 1025 - 1035 .
Buyang Huanwutang Alleviates Inflammatory Injury After Cerebral Ischemia-reperfusion in Rats via Activating Adiponectin Pathway
Inhibitory Effects of Ligustrazine Plus Emodin on Expression of VEGF-related Factors in Ascites Carcinoma Walker-256 Cells
Analysis of HPLC Characteristic Chromatogram of Standard Pieces of Polygoni Multiflori Radix
Apoptosis Mechanism of Emodin on Renal Toxicity in Mice
Effect of Diosgenin on Expressions of PPARγ, C/EBPα and Adipokine Secretion in Aplastic Anemia Mice
Related Author
GAO Yurong
ZHANG Yaxing
WU Fanghua
DAI Jiaying
LIU Wei
Ying-lan MAO
Mei ZHAO
Na HU
Related Institution
School of Basic Medical Sciences, Guangzhou University of Chinese Medicine
The Second Affiliated Hospital of Air Force Medical University
Key Laboratory of Digital Quality Evaluation Technology of Chinese Materia Medica, State Administration of Traditional Chinese Medicine(TCM), Engineering Technology Research Center for Chinese Materia Medica Quality of Universities in Guangdong Province, School of TCM, Guangdong Pharmaceutical University
College of Pharmacy, Chengdu University of Traditional Chinese Medicine